TempraMed Technologies Ltd. (9DY)

Overview

TempraMed Technologies Ltd. is a pioneering medical device technology company dedicated to developing innovative, patent-protected solutions for managing temperature-sensitive medications. The company's primary focus is on transforming injectors and storage systems for medications such as insulin, ensuring that these vital treatments remain effective during the critical 'last mile' transition from pharmacies to patients. TempraMed’s advanced devices, like the VIVI Cap, utilize space-grade thermal insulation and smart heat-absorbing materials, coupled with digital platforms for enhanced tracking and data sharing among patients, caregivers, and healthcare providers. With a commitment to creating hassle-free, battery-free solutions, TempraMed supports individuals with chronic conditions by providing protection for injectables on a global scale without the need for regular maintenance.

TempraMed Technologies Ltd. operates within the life sciences sector, incorporating manufacturing in the USA, assembly in Israel, and distribution through well-established pharmacy, retail, and government networks in diverse regions including Texas, Dubai, and Mumbai. Established in Israel and publicly listed since 2025, the company stands at the intersection of medical device engineering and digital health, focusing on enhancing patient safety and improving medication management processes.

Products and Services

• VIVI Cap

  The VIVI Cap is an innovative injector cap designed to protect temperature-sensitive medications such as insulin. This device leverages advanced insulation technology to maintain the required temperature, ensuring the potency and effectiveness of the medication during transport and storage.

• Smart Heat-Absorbing Materials

  These materials are integral to TempraMed's products, designed to absorb and retain heat, thereby stabilizing the temperature of medications. This feature plays a critical role in safeguarding injectables from temperature fluctuations that can undermine their effectiveness.

• Digital Tracking Platform

  TempraMed's digital platform allows for precise tracking and data sharing among patients, caregivers, and healthcare providers. This technology enhances communication and coordination in medication management, ensuring that all stakeholders have the necessary information regarding the medication’s status and conditions.

• Battery-Free Solutions

  The company specializes in creating hassle-free, battery-free medical devices, which simplify the usage of temperature-sensitive medications. By eliminating the need for batteries, these devices are more portable and require less maintenance, making them ideal for patients managing chronic conditions.

• Global Distribution Networks

  TempraMed's strategic partnerships with major pharmacy, retail, and government organizations across various regions, including the USA, Dubai, and Mumbai, ensure that its innovative devices reach patients where and when they need them, enhancing accessibility to essential medications.